Dr. Rugo on 20-Year Span of Breast Cancer Advancements

Dr. Rugo Discusses the Future of Angiogenesis in Breast CancerПодробнее

Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast CancerПодробнее

Dr. Rugo Discusses Guidelines for Metastatic Breast Cancer ManagementПодробнее

Dr. Rugo on Ongoing Trials in HER2+ Breast CancerПодробнее

Dr. Rugo on the Phase III SOPHIA Trial in HER2+ Breast CancerПодробнее

Dr. Rugo on the Efficacy of Bevacizumab in Breast CancerПодробнее

Breast Cancer: The Next Wave By Dr. Hope RugoПодробнее

Dr. Hope Rugo on Safety of Trastuzumab Biosimilar for HER2+ Breast CancerПодробнее

Dr. Rugo on Pathway Blockade in Breast CancerПодробнее

Message from Dr Hope Rugo on COVID 19 and Cancer PatientsПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

Dr. Rugo on the Advances in the Treatment of HER2-Positive Breast CancerПодробнее

Dr. Rugo on Chemotherapy for Metastatic Breast CancerПодробнее

Dr. Hope Rugo on the First-line Superiority of Paclitaxel for Advanced Breast CancerПодробнее

Ongoing Needs in HER2+ Breast CancerПодробнее

Dr. Rugo Discusses Immunotherapy in TNBCПодробнее

Dr. Rugo on SWISH Trial for HR-Positive Breast CancerПодробнее

ESMO 2019: Dr. Rugo Highlights Progress in Breast CancerПодробнее

Dr. Rugo on Hormone Therapy for Patients With Breast CancerПодробнее